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Tau protein is of primary importance for many physiological processes in neurons, where
it affects the dynamics of the microtubule system. When hyperphosphorylated (PP-Tau),
Tau monomers detach from microtubules and tend to aggregate firstly in oligomers, and
then in neurofibrillary tangles, as it occurs in a group of neurodegenerative disorders
named thauopathies. A hypothermia-related accumulation of PP-Tau, which is quickly
reversed after the return to normothermia, has been shown to occur in the brain of
hibernators during torpor. Since, recently, in our lab, a hypothermic torpor-like condition
(synthetic torpor, ST) was pharmacologically induced in the rat, a non-hibernator, the
aim of the present work was to assess whether ST can lead to a reversible PP-Tau
accumulation in the rat brain. PP-Tau was immunohistochemically assessed by staining
for AT8 (phosphorylated Tau) and Tau-1 (non-phosphorylated Tau) in 19 brain structures,
which were chosen mostly due to their involvement in the regulation of autonomic and
cognitive functions in relation to behavioral states. During ST, AT8 staining was strongly
expressed throughout the brain, while Tau-1 staining was reduced compared to control
conditions. During the following recovery period, AT8 staining progressively reduced
close to zero after 6 h from ST. However, Tau-1 staining remained low even after 38 h
from ST. Thus, overall, these results show that ST induced an accumulation of PP-Tau
that was, apparently, only partially reversed to normal during the recovery period. While
the accumulation of PP-Tau may only depend on the physicochemical characteristics of
the enzymes regulating Tau phosphorylation, the reverse process of dephosphorylation
should be actively regulated, also in non-hibernators. In conclusion, in this work a
reversible and widespread PP-Tau accumulation has been induced through a procedure
that leads a non-hibernator to a degree of reversible hypothermia, which is comparable
to that observed in hibernators. Therefore, the physiological mechanism involved in
this process can sustain an adaptive neuronal response to extreme conditions, which
may however lead to neurodegeneration when particular intensities and durations
are exceeded.
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INTRODUCTION
Tau protein is a microtubule-associated protein that is
predominantly present in neurons, where it is of primary
importance for many physiological processes due to
its effects on the dynamics of the microtubule system
(Wang and Mandelkow, 2016).
Tau tends to dissociate from microtubules when a
hyperphosphorylation (PP-Tau) substitutes the bound
physiological configuration of two phosphates per protein
molecule (Wang and Mandelkow, 2016). In certain conditions
and hyperphosphorylation states that are still largely unknown,
monomers of Tau aggregate in oligomers that, either by
coalescing in neurofibrillary tangles (NFT) or spreading as
neurotoxic agents, characterize a group of disorders defined
as tauopathies, ranging from Alzheimer’s disease (AD)
to neurodegenerative pathologies (Gerson et al., 2016;
Kovacs, 2017).
However, PP-Tau has been evidenced not only in tauopathy
subjects, but also in hamsters during torpor (Arendt et al., 2003),
as well as in mice (facultative hibernators; Hudson and
Scott, 1979) exposed to different physiological challenges, such
as starvation (Yanagisawa et al., 1999; Planel et al., 2001),
cold water stress (Okawa et al., 2003), or general anesthesia
(Planel et al., 2007). Remarkably, in all these conditions, PP-Tau
accumulation has been shown to be reversible.
The hypothermia that follows a decline in metabolic rate
appears to be key for PP-Tau induction (Arendt et al., 2015). This
was confirmed in mice made hypothermic either by starvation,
or by the i.p. administration of insulin or deoxyglucose
(Planel et al., 2004). Also, PP-Tau induction was suppressed in
mice that were kept euthermic while under general anesthesia
(Xiao et al., 2013).
The dynamics of hypothermia-related phosphorylation/
dephosphorylation of Tau protein, which have been widely
studied in either obligate or facultative hibernators, still have to
be clearly assessed in non-hibernating species. In fact, only an
indirect assessment of the degree of Tau phosphorylation has
been carried out in rats, suggesting a two–threefold increase
in several brain areas following cold-water stress exposure
(Korneyev et al., 1995). Recently, in our lab (Cerri et al., 2013),
a deep and fully reversible hypothermic state was induced in
the rat by the direct inhibition of the raphe pallidus (RPa),
the brain region containing the premotor sympathetic neurons
that control thermogenesis (Morrison and Nakamura, 2018).
This condition, defined as “synthetic torpor” (ST; Cerri, 2017),
is characterized by a decrease in body temperature that, being
induced by the central blockade of the final common pathway
of thermogenesis, is physiologically more similar to the process
that occurs in natural torpor-hibernation than when it is
induced by an external body cooling procedure that overwhelms
thermoregulatory responses.
The aim of the present work was to assess whether
the induction of ST in the rat coexisted with a reversible
accumulation of PP-Tau throughout the brain. To this end,
Tau phosphorylation was immunohistochemically assessed in
ST during the induction phase and the following recovery in
neural structures related to the regulation of autonomic (15) and
cognitive (4) functions in behavioral states.
MATERIALS AND METHODS
Animals
A total of 19 Male Sprague–Dawley rats (201–225 g; Charles
River) were used. Animals were acclimated to normal laboratory
conditions: ambient temperature (Ta) set at 24± 0.5◦C; 12 h:12 h
light-dark (LD) cycle (L: 09:00 h–21:00 h; 100–150 lux at
cage level); food and water ad libitum. All the experiments
were conducted following the approval by the National Health
Authority (decree: No. 112/2018-PR), in accordance with the
DL 26/2014 and the European Union Directive 2010/63/EU, and
under the supervision of the Central Veterinary Service of the
University of Bologna. All efforts were made to minimize the
number of animals used and their pain and distress.
Surgery
The procedure has been previously described (Cerri et al., 2013).
Briefly, deeply anesthetized rats (Diazepam, 5 mg/kg i.m.;
Ketamine-HCl, 100 mg/kg i.p.) were placed in a stereotaxic
apparatus (David Kopf Instruments) and surgically implanted
with: (i) electrodes for the electroencephalogram (EEG);
(ii) a thermistor (Thermometrics Corporation) mounted inside a
stainless steel needle (21 gauge) and placed beside the left anterior
hypothalamus to record the deep brain temperature (Tb);
(iii) a microinjection guide cannula, targeted to the RPa, at the
following coordinates from lambda: on the midline, 3.0 mm
posterior and 9.0 ventral to the dorsal surface of the cerebellum
(Paxinos and Watson, 2007). After surgery, animals received
20 ml/kg saline subcutaneously and 0.25 ml of an antibiotic
solution (penicillin G and streptomycin-sulfate) intramuscularly.
Each rat recovered from surgery for at least 1 week. Prior to
the experimental session rats were placed in a cage positioned
within a thermoregulated and sound-attenuated chamber. This
adaptation period was 3 days long, during which rats were
exposed to a mild low Ta (15◦C), constant darkness and were
fed a high-fat diet (35% fats, Mucedola), conditions that are
known to favor the occurrence of a torpid state in hibernators
(Cerri et al., 2013).
Synthetic Torpor
To induce ST, we used the consolidated protocol proposed by
Cerri et al. (2013). Briefly, a microinjecting cannula was inserted
into the guide cannula placed just above the RPa. Then, 100 nl of
the GABAA agonist muscimol (1 mM) was injected once an hour,
six consecutive times. Following the last injection, Tb reached
values of around 22◦C (Cerri et al., 2013). At 17.00 h, 1 h after
the last injection, Ta was set at 28 ± 0.5◦C to favor the return
to normothermia of the animal. A group of animals (Controls)
were injected with artificial cerebrospinal fluid (aCSF; EcoCyte
Bioscience). During the whole experiment, EEG and Tb signals
were recorded, after being opportunely amplified, filtered, and
digitalized (Cerri et al., 2013), at the aim of better monitoring
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animals’ behavior during ST induction and in the following
recovery period.
Experimental Procedure
Animals were randomly assigned to six different experimental
groups and were sacrificed at different times following the
injection of either muscimol or aCSF (first injection at 11.00 h).
Tb levels at the moment of the sacrifice are shown in Figure 1, for
each group. The experimental groups were the following:
– C→ Control, injected with aCSF (N = 2) and sacrificed at
around 17.00 h, exactly matching the N condition.
– N30→ sacrificed at around 12.00 h–13.00 h, between the
second and third injection of muscimol, when Tb reached
the level of 30◦C (N = 3).
– N → sacrificed 1 h after the last injection, at 17.00 h,
when Tb reached the nadir of hypothermia (N = 3;
Tb = 22.1± 1.4◦C).
– ER→ early recovery; sacrificed at around 19.00 h (2 h after
Ta was moved from 15 to 28◦C) when Tb reached 35.5◦C
after ST; at this specific point of the protocol, animals began
to show clear signs of sleep at the EEG level (N = 4).
– R6→ sacrificed at around 01.00 h, 6 h after ER (N = 4).
– R38→ sacrificed at around 09.00 h of the third day, 38 h
after ER (N = 3).
Immunohistochemistry
At the different time points of the experimental protocol,
rats under general anesthesia were transcardially perfused with
200 ml of saline solution (NaCl 0.9%, w/v) followed by an
equal amount of 4% (w/v) paraformaldehyde solution in sodium
phosphate buffer (PBS). The brain and spinal cord were extracted
and post-fixed for 2 h by immersion in the same solution used
for the perfusion. Then, both samples were put overnight in a
30% (w/v) sucrose solution in PBS and sodium-azide 0.02% (w/v)
for cryoprotection. Hereafter, tissue samples were embedded in a
cryostat cutting medium (Killik) and cut into 35 µm-thick slices
using a cryostat-microtome (Frigocut 2800), kept at −22.0◦C.
All the slices were then stored, until analyzed, at −80◦C in a
cryoprotectant solution: 30% (w/v) sucrose, 30% (v/v) ethylene
glycol, 1% (w/v) polyvinylpyrrolidone in PBS.
A sample of one out of every six slices of the whole brain
was used for immunostaining. Slices were rinsed twice in
PBS and then incubated for 2 h in 1% (v/v) normal donkey
serum. Consequently, all slices were incubated overnight with
the following primary antibodies: (i) monoclonal rabbit Anti-
NeuN (Merck-Millipore), a neuronal marker; (ii) monoclonal
mouse Anti-AT8 (Thermo Fisher), marker of the phospho-
[Ser202/Thr205]-Tau protein. Both primary antibodies were
diluted at 1:400. Slices were then rinsed twice in PBS with
0.3% (v/v) Triton X-100 and incubated with the following
secondary antibodies: (i) Donkey Anti-rabbit IgG conjugated
with Alexa-488 (Thermo Fisher); (ii) Donkey Anti-mouse IgG
conjugated with Alexa-594 (Thermo Fisher). Both secondary
antibodies were diluted at 1:500. Finally, tissue slices were
mounted on coated glass slices and coverslipped with an anti-fade
mounting medium (ProLong Gold mountant; Thermo Fisher).
As a control for the AT8 detection, the same procedure was
carried out using the monoclonal mouse Anti-Tau-1 (Merck-
Millipore; 1:400), followed by a Donkey Anti-mouse IgG
conjugated with Alexa-594 (1:500), that detects Tau protein when
it has no phosphorylation between residues from 189 to 207
(Szendrei et al., 1993; Billingsley and Kincaid, 1997). For this
procedure, only samples from C, N, and R38 were analyzed.
Since PP-Tau appears to be associated with
neuroinflammation (Davies et al., 2017; Nilson et al., 2017),
we also decided to assess the degree of activation of parenchymal
microglia in a small subgroup of experimental slide sets. The
activation state of microglia was evaluated qualitatively by
analyzing their morphology (Orr et al., 2009), following the
specific staining with the rabbit polyclonal Anti-Iba1 antibody
(1:800; Wako) and the secondary antibody Anti-rabbit IgG
conjugated with Alexa-488. The procedure was the same as
that described earlier in the text. The analysis of microglia
activation was conducted in one animal from each of the
FIGURE 1 | Schematic representation of the experimental procedure. The solid line indicates the progress of brain temperature (Tb) throughout the experiment. The
dotted line refers to the control group (C). The gray area represents the time period during which the synthetic torpor (ST) was induced, arrows indicate the injections
(see section “Materials and Methods”). N30, samples taken when Tb reached 30◦C; N, samples taken at nadir of hypothermia, during the ST; ER, early recovery,
samples taken when Tb reached 35.5◦C following ST; R6, samples taken 6 h after ER; R38, samples taken 38 h after ER.
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following experimental conditions: C, N, R6, and R38. Only
the following structures were analyzed: paraventricular nucleus
of the hypothalamus, CA3 field of the hippocampus, and
parietal cortex.
Image Acquisition and Analysis
Images were obtained with a Nikon eclipse 80i equipped
with Nikon Digital Sight DS-Vi1 color camera, at
100× magnification (200× for the microglia staining).
The 19 brain areas analyzed are shown in Figure 2, as a
diagram of their anatomical location and listed in Table 1
in a caudal to rostral direction: nucleus ambiguus (Amb);
dorsal motor nucleus of the vagus nerve (dMV); nucleus
of the solitary tract (NTS); raphe pallidus (RPa); locus
coeruleus (LC); lateral parabrachial nucleus (LPB); ventrolateral
part of the periaqueductal grey matter (VLPAG); medial
mammillary nucleus (MM); lateral hypothalamus (LH); arcuate
nucleus of the hypothalamus (Arc); dorsomedial nucleus of
the hypothalamus (DMH); paraventricular nucleus of the
hypothalamus (PVH); ventrolateral preoptic nucleus (VLPO);
median preoptic nucleus of the hypothalamus (MnPO);
paraventricular nucleus of the thalamus (PV); cerebellum
cortex (Cb-Cx); CA3 field of the hippocampus (CA3); perirhinal
cortex (PRh); parietal cortex (P-Cx). The visual recognition
of these structures was possible while observing NeuN
staining (Alexa-488) of the whole section and comparing it
with the atlas schemes. In particular, the experimenter at the
microscope was able to define the exact field to be digitally
acquired by easily recognizing some clear and unmistakable
neuroanatomical structures, such as: (i) for the brainstem: the
shape of the forth ventricle, the pyramidal tracts, the complex
of cochlear nuclei, the inferior olive complex of nuclei, the
facial nucleus, the typical caudo-rostral developing shape of
the Sylvius aqueduct, the typical shape of the middle cerebellar
peduncle; (ii) for the diencephalic structures: the shape of
the third ventricle, the lateral and dorso-ventral extension of the
hippocampus, the position of the fornix, the optic chiasm or the
shape of the optic tracts, the anterior commissure.
Following recognition, each microscopic field of interest was
acquired in two separate pictures that were distinct according
to the fluorochrome used, in order to have NeuN (Alexa-488)
for the anatomical identification and AT8 or Tau-1 (Alexa-594)
for the PP-Tau staining for each picture taken. In order to
create digital pictures with the best quality reproduction of the
variations of staining intensity observed for AT8 and Tau-1 at
the microscope, the exposure time of the camera was manually
FIGURE 2 | Schematic representation of the brain areas analyzed. Bregma level is reported on each panel; see also Table 1 for more details. Panel A: Amb, nucleus
ambiguus; NTS, nucleus of the solitary tract; dMV, dorsal motor nucleus of the vagus nerve; RPa, raphe pallidus; py, pyramidal tract. Panel B: LC, locus coeruleus.
Panel C: LPB, lateral parabrachial nucleus; mCP, middle cerebellar peduncle. Panel D: VLPAG, ventrolateral part of the periaqueductal gray matter; Aq, Sylvius
aqueduct. Panel E: MM, medial mammillary nuclei; 3V, third ventricle. Panel F: LH, lateral hypothalamus; Arc, arcuate nucleus of the hypothalamus; DMH,
dorsomedial nucleus of the hypothalamus; PV, paraventricular nucleus of the thalamus; CA3, field CA3 of the hippocampus; PRh, perirhinal cortex; P-Cx, parietal
cortex. Panel G: PVH, paraventricular nucleus of the hypothalamus; ot, optic tract. Panel H: VLPO, ventrolateral preoptic nucleus; MnPO, median preoptic nucleus of
the hypothalamus; ac, anterior commissure.
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TABLE 1 | Brain structures analyzed.
Brain structure Abbreviation Bregma level∗ Abbreviation(s) as in Paxinos and
Watson (2007)∗
Functional involvement Suggested references Panel in Figure 2
Medulla Nucleus ambiguus Amb −13/−13,5 AmbSC Autonomic function – Parasympathetic Brailoiu et al., 2017 A
Dorsal motor nucleus of the
vagus nerve
dMV −13/−13,5 10N Autonomic function – Parasympathetic Hopkins et al., 1996 A
Nucleus of the solitary tract NTS −13/−13,5 SolI; sol; SolC; SolIM; SolCe; SolL;
SolDL; SolM; SolV; SolVL; Psol
Visceral sensory integration – Central
autonomic regulation
Zoccal et al., 2014 A
Raphe pallidus Rpa −13/−13,5 Rpa Thermoregulation Morrison and Nakamura, 2018 A
Pons Locus coeruleus LC −9,6/−10,1 LC Behavioral state control Benarroch, 2018 B
Lateral parabrachial nucleus LPB −8,9/−9,2 LPBD; LPBCr; LPBE; LPBV; LPBI;
LPBC
Central autonomic regulation –
Thermoregulation
Morrison and Nakamura, 2018 C
Midbrain Ventrolateral part of the
periaqueductal gray matter
VLPAG −8,0/−8,5 VLPAG Central autonomic regulation –
Behavioral state control
Luppi, 2010 D
Hypothalamus Medial mammillary nucleus MM −4,2/−4,4 MnM; MM Memory formation and consolidation Vann and Nelson, 2015 E
Lateral hypothalamus LH −3,0/−3,4 PeFLH; PeF Behavioral state control – Regulation of
body metabolism
Luppi, 2018 F
Arcuate nucleus Arc −3,0/−3,4 ArcD; ArcM; ArcL Regulation of body metabolism Wu et al., 2014 F
Dorsomedial nucleus DMH −3,0/−3,4 DMC; DMD; DMV Thermoregulation Morrison and Nakamura, 2018 F
Paraventricular nucleus PVH −1,6/−1,9 PaMM; PaMP; PaV; PaDC; PaLM Central autonomic regulation –
Osmoregulation-Thermoregulation
McKinley et al., 2015; Morrison
and Nakamura, 2018
G
Ventrolateral preoptic
nucleus
VLPO −0,0/−0,6 VLPO Behavioral State Control –
Thermoregulation
Luppi, 2010 H
Median preoptic nucleus of
the hypothalamus
MnPO −0,1/−0,2 MnPO Central autonomic regulation –
Behavioral State Control –
Osmoregulation-Thermoregulation
McKinley et al., 2015; Morrison
and Nakamura, 2018
H
Thalamus Paraventricular nucleus PV −3,0/−3,4 PVP Central autonomic regulation Colavito et al., 2015 F
Cerebellum Cerebellar cortex Cb-Cx −11,5/−13,5 General sample picture from cortical
layers
Motor functions –Learning – Lack of
Tau phosphorylation in tauopathies
Hu et al., 2017 n.s.
Hippocampus CA3 field CA3 −3,0/−3,4 CA3; SLu; Rad Memory formation and consolidation –
Well studied for assessing Tau
phosphorylation in hibernators
Arendt et al., 2003, 2015 F
Brain Cortex Perirhinal cortex PRh −3,0/−3,4 PRh Memory formation and consolidation –
Recognition of environmental stimuli
Suzuki, 1996 F
Parietal cortex P-Cx −3,0/−3,4 Broadly covering primary
somatosensory cortex (S1Tr; S1DZ;
S1BF; S1ULp)
Sample of neocortex – Sensory
integration – Well studied for assessing
Tau phosphorylation in hibernators
Arendt et al., 2003, 2015 F
List of the brain neural structures analyzed, arranged in a caudal to rostral order. Structures directly involved in thermoregulation are shown in bold.
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regulated for each picture to the best of the experimenter
evaluations; the aim was to best reproduce on the taken picture
what observed directly through the oculars. The experimenter
was blind to the experimental conditions. The fine regulation
of the exposure time for every picture was necessary to avoid
automatic compensations of the camera, due to the dark field of
fluorescence images. All the other camera parameters, such as
white balance and gain (Y100-R100-B100), were kept constant
throughout the experiment. Thanks to the preview function of
the camera, all this procedure took very few seconds for each
picture, avoiding any problem of fluorescence fading.
Analyses were carried out independently by two
experimenters working in the same conditions: each
experimenter was unaware of the experimental conditions
and always used the same digital setup, with fixed brightness
and contrast regulations. PP-Tau accumulation was quantified
in each AT8 and Tau-1 picture, estimating the staining intensity
while observing pictures on the monitor (using Windows
Photo Viewer) by giving a score ranging from “−” (completely
absent) to “++++” (maximum staining) on a scale of five levels
(Supplementary Figure S1). The final score was obtained by
averaging the scores given by the two experimenters, considering
all the animals belonging to the same experimental condition.
Statistical Analysis
The analysis consisted in two steps: (i) “gross analysis”
considering together the scores of all the structures analyzed;
(ii) “fine analysis” considering structures separately.
We used the non-parametric Kruskal-Wallis test and, only
if the null hypothesis was rejected, pairwise comparisons were
carried out using the non-parametric Mann-Whitney test in the
following evaluations: (i) for AT8 staining: all the experimental
conditions vs. C; R6 vs. ER; R6 vs. R38; (ii) for Tau-1 staining: all
the experimental conditions vs. C; N vs. R38. Significance level
was preset at P < 0.05 for all comparisons.
No statistical analysis was conducted on the morphological
evaluation of the microglia activation.
RESULTS
Tau Phosphorylation: Gross Analysis
In this first step of the analysis, for each experimental condition
the scores relative to the 19 neural structures were considered
together as a whole.
When comparing scores obtained for the AT8 staining
intensity, as described in Table 2 and shown in the exemplificative
Figures 3–5, the results showed that staining levels in N30, N, and
ER were significantly higher than in Controls (P< 0.001 for each
comparison). Also, ER presented higher scores than those found
in R6, and this difference was statistically significant (P < 0.001).
R6 and R38 did not differ from each other (N.S.); nor were they
different from C (N.S. for both comparisons).
Concerning Tau-1 staining intensity, which is shown in
Table 2 and in Figure 6 as an example, the differences were
almost the reverse compared to those found for AT8 for both
C and N, but not for R38. In particular, staining levels in both
FIGURE 3 | Representative pictures showing the nucleus of the solitary tract
(NTS) and the motor nucleus of the vagus (dMV). Left column represents
NeuN staining (neuronal maker, secondary conjugated with Alexa-488), for the
recognition of the anatomical structures. Only for the top image, the
anatomical structures are marked with white dotted lines (calibration bar:
100 µm). Right column represents the same corresponding field depicted in
the left column, but stained for AT8 (phosphorylated Tau, secondary
conjugated with Alexa-594). C, control; N30, samples taken during the
induction of synthetic torpor (ST), when brain temperature (Tb) reached 30◦C;
N, samples taken at nadir of hypothermia, during the ST; ER, early recovery,
samples taken when Tb reached 35.5◦C following ST; R6, samples taken 6 h
after ER; R38, samples taken 38 h after ER. 4V, fourth ventricle.
N and R38 were significantly lower than those in C (P < 0.001
for each comparison). No substantial differences were observed
between N and R38.
Tau Phosphorylation: Fine Analysis
Considering AT8 staining, large and significant variations
were observed in the majority of the brain structures
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FIGURE 4 | Representative pictures showing the paraventricular nucleus of
the hypothalamus (PVH). Left column represents NeuN staining (neuronal
maker, secondary conjugated with Alexa-488), for the recognition of the
anatomical structure. Only for the top image, the anatomical structure is
marked with a white dotted line (calibration bar: 100 µm). Right column
represents the same corresponding field depicted in the left column, but
stained for AT8 (phosphorylated Tau, secondary conjugated with Alexa-594).
C, control; N30, samples taken during the induction of synthetic torpor (ST),
when brain temperature (Tb) reached 30◦C; N, samples taken at nadir of
hypothermia, during the ST; ER, early recovery, samples taken when Tb
reached 35.5◦C following ST; R6, samples taken 6 h after ER; R38, samples
taken 38 h after ER. 3V, third ventricle.
analyzed, although the results were rather heterogeneous
in the different structures. As far as Tau-1 staining is
concerned, only a few neural structures presented statistically
significant differences.
For clarity, these results will be described separately for each
experimental condition, although the whole scenario is shown in
Table 2 for both AT8 and Tau-1.
FIGURE 5 | Representative pictures showing the field CA3 of the
hippocampus (CA3). Left column represents NeuN staining (neuronal maker,
secondary conjugated with Alexa-488), for the recognition of the anatomical
structure. Only for the top image, the anatomical structure is identified
(calibration bar: 100 µm). Right column represents the same corresponding
field depicted in the left column, but stained for AT8 (phosphorylated Tau,
secondary conjugated with Alexa-594). C, control; N30, samples taken during
the induction of synthetic torpor (ST), when brain temperature (Tb) reached
30◦C; N, samples taken at nadir of hypothermia, during the ST; ER, early
recovery, samples taken when Tb reached 35.5◦C following ST; R6, samples
taken 6 h after ER; R38, samples taken 38 h after ER.
N30 (Samples Taken During the Induction of ST;
Figure 1)
In this experimental condition, statistically significant higher AT8
staining levels compared to C were only found in six structures
mainly involved in thermoregulatory and metabolic control
(Table 1): LPB (P = 0.006), MM (P = 0.006), Arc (P = 0.021), PVH
(P = 0.008), VLPO (P = 0.006), and MnPO (P = 0.046).
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FIGURE 6 | Representative pictures showing the paraventricular nucleus of
the hypothalamus (PVH). Left column represents NeuN staining (neuronal
maker, secondary conjugated with Alexa-488), for the recognition of the
anatomical structure. Only for the top image, the anatomical structure is
marked with a white dotted line (calibration bar: 100 µm). Right column
represents the same corresponding field depicted in the left column, but
stained for Tau-1 (non-phosphorylated Tau, secondary conjugated with
Alexa-594). C, control; N, samples taken at nadir of hypothermia, during the
synthetic torpor (ST); R38, samples taken 38 h after
35.5◦C brain temperature was reached. 3V, third ventricle.
N (Samples Taken During ST, at the Nadir of Tb;
Figure 1)
As shown in Table 2, in this experimental condition the
large majority of the structures that were analyzed presented a
significantly higher staining intensity for AT8 compared to C.
In particular: Amb (P = 0.003), NTS (P = 0.008), dMV (P = 0.048),
LC (P = 0.021), LPB (P = 0.006), Cb-Cx (P = 0.003), MM
(P = 0.006), LH (P = 0.026), Arc (P = 0.007), DMH (P = 0.006),
PVH (P = 0.006), PV (P = 0.006), VLPO (P = 0.006), MnPO
(P = 0.008), CA3 (P = 0.009), and PRh (P = 0.046). In contrast,
only a few structures did not show differences compared to C:
RPa, VLPAG and P-Cx (NS, for all these comparisons).
Table 2 also shows that the staining intensity of Tau-1 was
lower than that found in C for the following structures: LH
(P = 0.041), Arc (P = 0.038), PVH (P = 0.046), VLPO (P = 0.046),
MnPO (P = 0.016), and P-Cx (P = 0.014).
ER (Samples Taken During the Early Recovery From
ST, When Tb Reached 35.5◦C; Figure 1)
In this condition, the staining intensity found for AT8 was still
significantly higher than in C for the majority of the structures
in which an hyperphosphorylation was observed in N: Amb
(P = 0.041), LPB (P = 0.005), MM (P = 0.005), LH (P = 0.026),
Arc (P = 0.006), DMH (P = 0.028), PVH (P = 0.003), VLPO
(P = 0.011), MnPO (P = 0.023), and CA3 (P = 0.026).
R6 (Samples Taken 6 h After ER; Figure 1)
After 6 h of the recovery from the re-attainment of euthermia
following ST, significant differences of staining intensity for
AT8 compared to C were very limited: in NTS the intensity
was significantly lower (P = 0.041), the same being true for
VLPAG (P = 0.041), LH (P = 0.041), CA3 (P = 0.041), and P-Cx
(P = 0.041). Only in MM results show a significantly higher
(P = 0.041) staining intensity compared to C.
Moreover, in order to better assess the dynamics of
de-phosphorylation, AT8 staining intensity data from this
experimental condition were also compared with ER. The
staining intensity resulted significantly lower in R6 in the large
majority of the structures analyzed: Amb (P = 0.011), NTS
(P = 0.001), RPa (P = 0.020), LPB (P< 0.001), VLPAG (P = 0.027),
MM (P = 0.010), LH (P < 0.001), Arc (P = 0.006), DMH
(P = 0.030), PVH (P< 0.001), PV (P = 0.025), VLPO (P = 0.009),
MnPO (P = 0.016), CA3 (P < 0.001), PRh (P = 0.025), and
P-Cx (P = 0.003).
R38 (Samples Taken 38 h After ER; Figure 1)
Results from this late-recovery condition, regarding the AT8
staining intensity, were very similar to those of C. The only
statistically significant difference was that relative to the PVH
(P = 0.046), in which the staining resulted slightly higher
in R38 than in C.
Lastly, AT8 data from this experimental condition were also
compared with the R6 condition. Once again the only statistically
significant difference was relative to the PVH (P = 0.008), with a
staining intensity slightly higher in R38 than in R6.
Concerning Tau-1, the staining intensity found in this
experimental condition was significantly lower than that found
in C for the following structures: RPa (P = 0.005), LH (P = 0.007),
PRh (P = 0.008), and P-Cx (P = 0.027).
DISCUSSION
The results of this work show that ST induced a reversible
accumulation of PP-Tau in the brain, in a species, the rat, that
is unable to spontaneously enter a torpor-hibernation state.
In selected brain areas of rats exposed to cold-water stress,
Korneyev et al. (1995) observed a two-fold increase in the
immunoreactivity of the Tau paired helical filaments, which
normalized 3 h after the end of the stress procedure. In this
case, however, both the method of inducing hypothermia and
its estimated degree (Hannon, 1958) were far different from
those used in our study or from the conditions that occur
physiologically in hibernators. Hence, our results may expand the
view of hypothermia as a model for studying either the physiology
or the pathology of Tau (Wang and Mandelkow, 2016).
In fact, the possibility to fully control ST (Cerri et al., 2013;
Tupone et al., 2013) permits to handle and to reproduce degrees
and durations of hypothermia in non-hibernating mammals that
are commonly used in laboratory studies to an extent that is
comparable to that of hibernators.
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TABLE 2 | AT8 and Tau-1 staining intensities.
AT8 Tau-1
C N30∗ N∗ ER∗ R6# R38 C N∗ R38∗
Amb − +++ ++∗ +∗ −# − ++ ++ +
NTS + + ++∗ ++ −∗# − ++ ++ ++
dMV + ++ ++∗ ++ − − ++ ++ ++
Rpa ++ ++ +++ ++ +# ++ + + −∗
LC − ++ +∗ + − − ++ ++ ++
LPB − +∗ ++∗ ++∗ −# − ++ + +
VLPAG + + + + −∗# − +++ ++ ++
Cb-Cx − + +∗ + − − + + +
MM − ++∗ ++++∗ ++∗ +∗# + ++ ++ ++
LH + ++ +++∗ ++∗ −∗# − +++ +∗ ++∗
Arc − ++∗ +++∗ ++∗ +# + +++ ++∗ ++
DM − + +∗ +∗ −# − +++ + ++
PVH − +++∗ +++∗ ++∗ −#§ +∗ +++ +∗ ++
PV − + +∗ + −# − +++ ++ ++
VLPO − +++∗ ++++∗ +∗ −# + +++ ++∗ ++
MnPO − ++∗ +++∗ +∗ −# − +++ +∗ ++
CA3 + + +++∗ ++∗ −∗# − ++ + +
PRh − ++ +∗ + −# − ++++ ++ ++∗
P-Cx + ++ + + −∗# − +++ +∗ ++∗
Brain structures are listed in order from caudal to rostral. See Table 1 and Figure 2 for acronym definition. Staining intensities are represented in a qualitative scale (see
Supplementary Figure S1), ranging from “−” (no staining) to “++++” (maximum staining observed). Results are the average of two independent blind evaluations by
different experimenters. C, control; N30, samples taken during the induction of synthetic torpor (ST), when brain temperature (Tb) reached 30◦C; N, samples taken at
nadir of hypothermia, during the ST; ER, early recovery, samples taken when Tb reached 35.5◦C following ST; R6, samples taken 6 h after ER; R38, samples taken 38 h
after ER. Statistically significant differences (P < 0.05) are shown: ∗ vs. C; #R6 vs. ER; § R6 vs. R38.
Since we suppose that the development and the resolution
of the processes underlying PP-Tau accumulation are driven by
different mechanisms, we will discuss them separately.
Hypothermia-Induced Phosphorylation
of Tau Protein
Our results show that, during ST, Tau was hyperphosphorylated
throughout the brain, both at N30 and N. Synthetic torpor leads
to a degree of hypothermia (Cerri et al., 2013) which cannot
be safely reached by a non-hibernating mammal. Therefore,
our results suggest that an evolutionarily ancestral and highly
conserved process is active in rat neurons.
Deep hypothermia acts as a main trigger for PP-Tau
accumulation, as already described in hibernators
(Arendt et al., 2003, 2015) and in mice (Planel et al., 2004, 2007).
The accumulation of PP-Tau in hypothermic conditions
may depend on the physicochemical characteristics of the
main enzymes involved in the phosphoregulation of Tau
protein: the glycogen-synthase kinase-3-β (GSK3-β) and
the protein-phosphatase-2A (PP2A) (Planel et al., 2004;
cf. Gerson et al., 2014). In fact, at low Ta the deactivation of
PP2A is faster and larger than that of GSK3-β and, consequently,
kinase activity may for some time exceed that of phosphatase
(Planel et al., 2004; Su et al., 2008). Specific regulatory
mechanisms may also be active in this process, since in
hypothermic anesthesia PP-Tau accumulation was shown
to be concomitant with an inhibition of the activity
of PP2A, while no changes emerged for the activity
of several kinases, among which GSK3-β was shown,
however, to undergo an inhibitory phosphorylation (Planel
et al., 2007). Furthermore, the study of hibernation
showed active inhibitory processes on PP2A and
GSK3-β during hypothermic bouts (Su et al., 2008;
Stieler et al., 2011).
Even though the majority of neural structures analyzed
here showed a PP-Tau accumulation peak in the N condition,
some specific structures, among whom, the PV and parietal
and cerebellar cortices did not, maintaining low levels of AT8
immunoreactivity (AT8-IR). Regional specific differences in
AT8-IR have already been described, highlighting a lower
AT8-IR in the aforementioned neural structures both in AD
patients (Braak et al., 2006; Hu et al., 2017; cf. Furman et al., 2017)
and hibernating mammals (Stieler et al., 2011). The functional
interpretation of this regional differentiation is rather difficult,
and other experiments need to be conducted on this account.
However, one suggestion comes from data by Hu et al. (2017),
which showed that, in the rat, GSK3-β and PP2A expressions
were significantly lower in the cerebellum compared to the
hippocampus and cerebral cortex.
Furthermore, in accordance with previous observations
(Korneyev et al., 1995; Yanagisawa et al., 1999;
Planel et al., 2007), in the present work the Tau-1 staining
(that evidences only the non-phosphorylated Tau) was
higher in euthermic controls than in ST in all the nervous
structures examined.
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In conclusion, the strong parallelism of overall PP-Tau
accumulation between ST, natural hibernation, and AD,
corroborate the possibility of a common mechanism underlying
the cellular processes observed in all these cases.
Resolution of the Accumulation of
Phosphorylated Tau Protein During
Recovery From ST
Results from the recovery period that follows ST appear of
particular interest. Up to now, the reversibility of a strong
and diffuse PP-Tau was observed only in hibernating mammals
(Planel et al., 2004, 2007; Stieler et al., 2011; Arendt et al., 2015).
Our results show that soon after 6 h from the recovery of
normothermia following the ST, all the brain structures analyzed
solved the AT8-IR, reaching levels that were not different from C.
The dephosphorylation of Tau does not evidently follow
the temperature-dependent regulation of the enzymatic activity.
In fact, following the formerly described kinetics in the
opposite direction, during body rewarming GSK3-β should be
the first enzyme to recover its activity (Stieler et al., 2011).
Therefore, while returning to normal Tb after the ST bout, there
should be an additional period of time during which GSK3-β
could act on Tau protein without being contrasted by PP2A
(Planel et al., 2004), leading to further phosphorylation.
This suggests that the resolution of the PP-Tau condition is an
actively regulated process, although the underlying mechanisms
are still unknown.
Apart from the involvement of the activity regulation of PP2A
(Planel et al., 2007), other mechanisms have been described that
could explain the PP-Tau resolution. In fact, PP-Tau may be
released by neurons with an activity-dependent process (Serrano-
Pozo et al., 2011; Yamada et al., 2011; Pooler et al., 2013),
and dephosphorylated in the brain interstitial fluid, which is
rich in non-specific phosphatases (Díaz-Hernández et al., 2010).
Indeed, it has been observed that patients suffering from AD
show much higher levels of Tau than of PP-Tau in CSF (Tapiola
et al., 2009). The association between the secretion of PP-Tau
and this phosphatasic activity may be an important regulated
process that could explain the rapid resolution of PP-Tau
following the ST.
In addition to AT8-IR data, Tau-1 immunoreactivity
(Tau-1-IR) shows that the dephosphorylation of Tau protein is
not complete and the condition reached 38 h after the recovery of
normothermia from ST is not exactly the same as that observed
in controls, even though rats showed an apparently normal
behavior and a normal wake-sleep pattern (Cerri et al., 2013).
Notably, a similar dissociation between AT8-IR and
Tau1-IR was reported in hibernators (Arendt et al., 2003;
Planel et al., 2007). Differently, a normalization of Tau1-IR
was observed in rats exposed to cold-water stress by
Korneyev et al. (1995) in the aforementioned study.
An interpretation of these findings may lie in the specificity
of the antibodies used: Tau-1 recognizes Tau protein only
when it is not phosphorylated between residues 189 and 207
(Szendrei et al., 1993; Billingsley and Kincaid, 1997), while AT8
recognizes Tau phosphorylated at Ser202/Thr205/Ser208
(Malia et al., 2016). Our results showed this specular
recognition by the two antibodies only in the C and N
conditions: when AT8-IR is high, Tau-1-IR is low, and
vice-versa. However, in R38 both antibodies showed a low
immunoreactivity. This lack of IR of both AT8 and Tau-1
in R38 may be interpreted as a partial dephosphorylation
targeted to AT8-specific epitopes of Tau monomers. Notably,
if this partial dephosphorylation of Tau is targeted to Ser202,
the outcome from ST might even have a neuroprotective
effect, since Tau phosphorylation at Thr205 appears to
inhibit amyloid-β toxicity in an Alzheimer’s mouse model
(Ittner et al., 2016). However, a long-term aversive outcome
for neurons may not be excluded from the present data,
since 38 h of observation post-ST are not comparable
with the long period needed to develop neurodegeneration
in animal models of tauopathies (Mustroph et al., 2012;
Zhang et al., 2018). Notwithstanding this limit, the analysis
of the wake-sleep behavior of rats during the first recovery
day following ST (Cerri et al., 2013) suggests that ST does not
produce a functional aversive effect.
A further element that may help in understanding the process
of resolution of the accumulation of PP-Tau during the recovery
from ST comes from a preliminary observation on the possible
involvement of microglia in this process, which has been carried
out in the present study. It is known that microgliosis, a crucial
step in neuroinflammation that is characterized by an activation
and proliferation of microglia, is an important hallmark of
tauopathies (Ransohoff, 2016; Nilson et al., 2017).
Considering the limitation of our analysis, carried out in
only one subject per condition, no relevant modifications in cell
morphology, which are considered to be a sign of microglia
activation (Stence et al., 2001; Morrison and Filosa, 2013), were
observed throughout the experimental protocol in any structure
analyzed, as shown in Supplementary Figure S1 for CA3.
Although some changes in hippocampal microglia morphology
were observed in hibernating hamsters (Cogut et al., 2018;
León-Espinosa et al., 2018), a normalization to the euthermic
control values occurred at the eighth hour from the end of the
torpor bout (Cogut et al., 2018).
However, in the present study we observed a visibly
higher microglia density in R6 for all the structures analyzed
(Supplementary Figure S2, for CA3), while no such relevant
differences were highlighted in R38 compared to C. This
suggests that in R6 a transient and mild inflammatory
process, apparently reverting toward normal conditions, is
occurring. Interestingly, a transient increase of the synthesis
of pro-inflammatory cytokines (IL-6, IL-1β) was observed in
hibernating hamsters during the 8-h period which followed
the torpor bout (Cogut et al., 2018). Microglia are known
to be stimulated by extracellular Tau protein (Asai et al.,
2015) and in tauopathies they seem to have a role in
spreading Tau-tangles throughout the different brain regions
(Asai et al., 2015; Bussian et al., 2018). Accordingly, in
the R6 condition, when the resolution of AT8-IR is at its
maximal rate, a certain level of microgliosis may sustain the
clearance of the PP-Tau, that is possibly secreted by neurons
(Serrano-Pozo et al., 2011; Asai et al., 2015).
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CONCLUSION
In the present paper, the induction and reversibility of a
widespread PP-Tau accumulation has been described for
the first time in a non-hibernating mammal, through an
experimental model that makes it possible to take a non-
hibernator to a degree of reversible hypothermia comparable
to that occurring in hibernators. While the induction of
PP-Tau accumulation seems to be due to physicochemical
mechanisms, its resolution appears to be actively regulated,
possibly involving microglia. Therefore, the physiological
mechanism involved in this process can sustain an adaptive
neuronal response to extreme conditions, which may however
lead to neurodegeneration when particular intensities and
durations are exceeded.
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